GCM
MXCT icon

Graham Capital Management’s MaxCyte MXCT Stock Holding History

Graham Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,871
Closed -$7.64K – 1414
2026
Q1 		$7.64K Sell
10,871
-44,865
-80% -$41.9K ﹤0.01% 1119
2025
Q4 		$86.4K Buy
55,736
+29,330
+111% +$46.8K ﹤0.01% 1146
2025
Q3 		$41.7K Buy
+26,406
New +$45.9K ﹤0.01% 1197
2025
Q2 		– Sell
-36,726
Closed -$100K – 1495
2025
Q1 		$100K Buy
36,726
+13,679
+59% +$53.9K ﹤0.01% 1213
2024
Q4 		$95.9K Buy
+23,047
New +$87.1K ﹤0.01% 1160

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Graham Capital Management's MXCT Position: Q2 2026 in Review

Graham Capital Management sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 10,871 shares — an estimated $7.64K sold.

Graham Capital Management first reported a position in MXCT in Q4 2024 and held it in 5 quarters. The position peaked at $100K in Q1 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Graham Capital Management reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 10,871 MaxCyte shares in Q2 2026, an estimated $7.64K.
  • Graham Capital Management first reported a position in MaxCyte in Q4 2024 and held it in 5 quarters.
  • Graham Capital Management's MaxCyte position peaked at $100K in Q1 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.